Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis | Zendy

Sara Panizo | Zendy; S. Barrio-Vazquez | Zendy; Manuel NavesDíaz | Zendy; Natalia CarrilloLópez | Zendy; Isabel Rodrı́guez | Zendy; Amalia Fernández-Vázquez | Zendy; José Manuel Valdivielso | Zendy; Ravi Thadhani | Zendy; Jorge B. CannataAndía | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis

Author(s) -

Sara Panizo,

S. Barrio-Vazquez,

Manuel NavesDíaz,

Natalia CarrilloLópez,

Isabel Rodrı́guez,

Amalia Fernández-Vázquez,

José Manuel Valdivielso,

Ravi Thadhani,

Jorge B. CannataAndía

Publication year - 2013

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gft268

Subject(s) - medicine , paricalcitol , endocrinology , left ventricular hypertrophy , fibrosis , myocardial fibrosis , calcitriol receptor , brain natriuretic peptide , cardiac fibrosis , atrial natriuretic peptide , kidney disease , calcitriol , natriuretic peptide , ventricular remodeling , vitamin d and neurology , heart failure , blood pressure , calcium , secondary hyperparathyroidism , parathyroid hormone

Left ventricular hypertrophy (LVH), a common complication in chronic kidney disease (CKD), is associated with high cardiovascular mortality. The aim of this experimental study was to analyze the effect of different vitamin D receptor activators (VDRAs) on both LVH and myocardial fibrosis in chronic renal failure (CRF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research